Aurora Spine saw a 7.1% year-over-year decrease in third-quarter sales, according to financial results posted Nov. 18.
Five things to know:
1. Quarterly sales were $4.43 million, which is down from $4.77 million in the same time last year. This is attributed to decreases in lumbar spine sales as the company transitioned from a third-party lumbar screw to the Osteo Onyx.
2. Operating expenses were $2.81 million, the same as during the third quarter of 2024.
3. Aurora Spine saw a net loss of $142,000.
4. The third quarter of 2025 is the fifth consecutive quarter Aurora Spine had with at least $4.4 million in sales.
5. CEO called this quarter “one of transition” as the company integrated the DEXA-L and Hydra ARO platforms, according to a news release.
“These two launches round out the company’s mission of pivoting to developing and selling proprietary products,” he said in the release. “Now that these products have been launched, our team is highly focused on commercializing all of our product platforms. Initial feedback of these two new product launches has been extremely positive and should act as excellent growth catalysts for Aurora Spine in the years to come.”
